194 related articles for article (PubMed ID: 23268621)
1. Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy.
Kuo YH; Lin CH; Shau WY; Chen TJ; Yang SH; Huang SM; Hsu C; Lu YS; Cheng AL
BMC Cancer; 2012 Dec; 12():620. PubMed ID: 23268621
[TBL] [Abstract][Full Text] [Related]
2. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
Ali AM; Ueno T; Tanaka S; Takada M; Ishiguro H; Abdellah AZ; Toi M
Eur J Cancer; 2011 Oct; 47(15):2265-72. PubMed ID: 21737256
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.
Beaudry P; Force J; Naumov GN; Wang A; Baker CH; Ryan A; Soker S; Johnson BE; Folkman J; Heymach JV
Clin Cancer Res; 2005 May; 11(9):3514-22. PubMed ID: 15867254
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
DuBois SG; Stempak D; Wu B; Mokhtari RB; Nayar R; Janeway KA; Goldsby R; Grier HE; Baruchel S
Pediatr Blood Cancer; 2012 Feb; 58(2):181-4. PubMed ID: 21319292
[TBL] [Abstract][Full Text] [Related]
5. Alterations of circulating endothelial cell and endothelial progenitor cell counts around the ovulation.
Tanaka S; Ueno T; Sato F; Chigusa Y; Kawaguchi-Sakita N; Kawashima M; Fujisawa N; Yoshimura K; Teramukai S; Fujiwara H; Fujita M; Toi M
J Clin Endocrinol Metab; 2012 Nov; 97(11):4182-92. PubMed ID: 22948762
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Vasseur A; Cabel L; Tredan O; Chevrier M; Dubot C; Lorgis V; Jacot W; Goncalves A; Debled M; Levy C; Ferrero JM; Jouannaud C; Luporsi E; Mouret-Reynier MA; Dalenc F; Lemonnier J; Savignoni A; Tanguy ML; Bidard FC; Pierga JY
Angiogenesis; 2020 May; 23(2):193-202. PubMed ID: 31773439
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.
Bidard FC; Mathiot C; Degeorges A; Etienne-Grimaldi MC; Delva R; Pivot X; Veyret C; Bergougnoux L; de Cremoux P; Milano G; Pierga JY
Ann Oncol; 2010 Sep; 21(9):1765-1771. PubMed ID: 20233745
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
9. High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.
Shao YY; Lin ZZ; Chen TJ; Hsu C; Shen YC; Hsu CH; Cheng AL
Oncology; 2011; 81(2):98-103. PubMed ID: 21986371
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.
Santini D; Zoccoli A; Gregorj C; Di Cerbo M; Iuliani M; Pantano F; Zamarchi R; Sergi F; Flammia G; Buscarini M; Rizzo S; Cicero G; Russo A; Vincenzi B; Avvisati G; Tonini G
Oncology; 2013; 85(6):342-7. PubMed ID: 24335337
[TBL] [Abstract][Full Text] [Related]
11. Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma.
Namdarian B; Tan KV; Fankhauser MJ; Nguyen TT; Corcoran NM; Costello AJ; Hovens CM
BJU Int; 2010 Oct; 106(7):1081-7. PubMed ID: 20201835
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.
Mancuso P; Colleoni M; Calleri A; Orlando L; Maisonneuve P; Pruneri G; Agliano A; Goldhirsch A; Shaked Y; Kerbel RS; Bertolini F
Blood; 2006 Jul; 108(2):452-9. PubMed ID: 16543470
[TBL] [Abstract][Full Text] [Related]
13. Circulating endothelial cells and circulating endothelial progenitors.
Mancuso P; Calleri A; Bertolini F
Recent Results Cancer Res; 2012; 195():163-70. PubMed ID: 22527503
[TBL] [Abstract][Full Text] [Related]
14. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.
Cattin S; Fellay B; Pradervand S; Trojan A; Ruhstaller T; Rüegg C; Fürstenberger G
Oncotarget; 2016 Mar; 7(10):11137-50. PubMed ID: 26840567
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cells as a novel marker of angiogenesis.
Mancuso P; Calleri A; Cassi C; Gobbi A; Capillo M; Pruneri G; Martinelli G; Bertolini F
Adv Exp Med Biol; 2003; 522():83-97. PubMed ID: 12674213
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Goon PK; Lip GY; Stonelake PS; Blann AD
Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
Bertolini F
Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
[TBL] [Abstract][Full Text] [Related]
20. Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancer.
Sakamori Y; Masago K; Ohmori K; Togashi Y; Nagai H; Okuda C; Kim YH; Ichiyama S; Mishima M
Cancer Sci; 2012 Jun; 103(6):1065-70. PubMed ID: 22360644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
